JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A8206 Darunavir
2 Citation

Summary: HIV-1 protease inhibitor

≥22.65 mg/mL
A8201 Amprenavir (agenerase)

Summary: HIV-1 protease inhibitor
A4049 Marimastat
1 Citation

Target: MMP

Summary: MMPs inhibitor,board spectrum

≥2.8 mg/mL
A4050 GM 6001
2 Citation

Target: MMP

Summary: Broad spectrum MMP inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL
A4051 NSC 405020
1 Citation

Target: MMP

Summary: MT1-MMP inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4052 Doxycycline hyclate

Target: MMP

Summary: matrix metalloproteinases inhibitor

≥22.15 mg/mL
A4114 MLN8054

Target: Aurora Kinases

Summary: Aurora A inhibitor

insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
A4115 JNJ-7706621
1 Citation

Target: Cyclin-Dependent Kinases|Aurora Kinases

Summary: Potent CDK/Aurora kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL
A4116 Danusertib (PHA-739358)
2 Citation

Target: Aurora Kinases

Summary: Pan-aurora kinase inhibitor

≥23.75 mg/mL
A1115 Peptide YY(3-36), PYY, human

Target: NPY Receptors

Summary: Y2R agonist

≥405 mg/mL